Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC6A16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBALD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPUL2-BSCL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUSBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUDT9P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CC2D1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCHO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00612 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRACR2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on